S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
STTK · Shattuck Labs, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Shattuck Labs Inc (STTK)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$5.57
-0.29
(-4.95%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$5.57
$5.57
$5.97
52-WEEK RANGE
$5.57
$1.72
$8.33
What's happening
- STTK is down 4.95% today, trading at $5.57. — Live quote
- Volume today (83,437) is well below its 3-month average of 1,330,610. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.12 actual vs. $-0.12 estimated (-0.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 10
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (17 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
STTK
+60.00%
vs S&P 500
+47.22%
1-YEAR RETURN
STTK
+178.10%
vs S&P 500
+163.53%
6-MONTH RETURN
STTK
-20.54%
3-MONTH RETURN
STTK
-19.00%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.12
Est. $-0.12
MISS -0.3%
2026-04-26 (Q1 2026)
$-0.13
Est. $-0.14
BEAT +7.7%
2026-01-26 (Q4 2025)
$-0.12
Est. $-0.14
BEAT +13.9%
2025-10-26 (Q3 2025)
$-0.14
Est. $-0.15
BEAT +7.7%
Valuation Measures & Ratios
Enterprise Value4$520.8M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)584.11
Price / Book72.97
EV4 / Revenue520.82
EV4 / EBITDA—
Profit Margin-1005.60%
Operating Margin-1071.60%
Return on Equity (ROE8)-43.57%
Return on Assets (ROA9)-40.90%
Avg Volume (3M)1,330,610
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $877.6M | $731.0M | $169.5M | $41.2M | $48.7M |
| P/E | -16.74 | -14.34 | -3.20 | -0.64 | -0.69 |
| Price/Sales | 877.55 | 730.97 | 42.41 | 8.94 | 8.52 |
| Price/Book | 4.16 | 7.63 | 1.82 | 0.72 | 0.72 |
| EV/Revenue | 814.25 | 640.55 | 31.77 | -2.01 | -2.13 |
| ROE | -24.83% | -53.20% | -56.73% | -112.92% | -104.21% |
| ROA | -23.76% | -49.92% | -52.72% | -100.02% | -91.27% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short10,947,042
Change from Prior Settlement+60.78%
% of Float—
Days to Cover (Short Ratio)6.01
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +178.1%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-08-11; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -36.8% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -1005.6%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on STTK
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1.0M | $0 | $0 | $3.0M | $1.6M | $1.1M |
| Operating income | -$16.2M | -$15.5M | -$10.7M | -$13.0M | -$14.4M | -$17.9M | -$23.0M | -$20.0M |
| Net income | -$15.2M | -$14.8M | -$10.1M | -$12.5M | -$13.7M | -$16.7M | -$21.6M | -$18.5M |
| EPS (diluted) | $-0.12 | $-0.13 | $-0.14 | $-0.24 | $-0.27 | $-0.33 | $-0.42 | $-0.37 |
| EPS (basic) | $-0.12 | $-0.13 | $-0.14 | $-0.24 | $-0.27 | $-0.33 | $-0.42 | $-0.37 |
| Operating margin | — | — | -$1.1K | — | — | -$598 | -$1.4K | -$1.8K |
| Net margin | — | — | -$1.0K | — | — | -$556 | -$1.3K | -$1.7K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $220.7M | $102.1M | $91.0M | $100.3M | $64.4M | $77.2M | $91.0M | $111.7M |
| Total liabilities | $9.5M | $6.3M | $8.6M | $7.1M | $7.4M | $9.6M | $11.4M | $15.1M |
| Stockholders' equity | $211.1M | $95.8M | $82.4M | $93.2M | $57.0M | $67.6M | $79.6M | $96.6M |
| Total current assets | $213.3M | $93.8M | $82.5M | $90.7M | $54.7M | $66.4M | $79.2M | $98.7M |
| Total current liabilities | $7.7M | $4.2M | $7.1M | $5.3M | $5.3M | $7.3M | $8.9M | $12.4M |
| Cash & equivalents | $63.3M | $90.4M | $54.2M | $42.5M | $50.5M | $60.9M | $57.4M | $43.8M |
| Property, plant & equipment | $4.5M | $5.4M | $6.1M | $7.1M | $7.9M | $8.9M | $9.8M | $10.8M |
| Other non-current assets | $1.9M | $2.0M | $1.4M | $2.6M | $1.7M | $1.9M | $2.0M | $2.2M |
| Accounts payable | $3.9M | $1.3M | $2.1M | $1.2M | $475.0K | $1.5M | $2.4M | $2.9M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $10.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K |
| Retained earnings | -$460.4M | -$445.3M | -$430.5M | -$417.9M | -$407.9M | -$395.4M | -$381.7M | -$363.0M |
| Accumulated other comprehensive income (loss) | -$63.0K | $0 | $6.0K | $3.0K | $1.0K | $0 | $2.0K | $52.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$10.2M | -$13.4M | -$8.5M | -$8.9M | -$10.4M | -$12.0M | -$17.4M | -$16.1M |
| Investing cash flow | -$144.9M | $23.8M | $20.0M | -$43.5M | $0 | $15.6M | $31.0M | -$821.0K |
| Financing cash flow | $128.0M | $25.8M | $134.0K | $44.5M | $0 | -$57.0K | -$72.0K | $23.0K |
| Free cash flow | -$10.3M | — | -$8.5M | -$9.0M | -$10.4M | — | -$17.4M | -$16.1M |
| Capital expenditures | $141.0K | — | $0 | $71.0K | $0 | — | $0 | $42.0K |
| Depreciation & amortization | — | — | $3.7M | — | — | — | $3.8M | — |
| Share-based compensation | $2.7M | $2.4M | $1.6M | $1.8M | $1.9M | $1.7M | $1.9M | $2.6M |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in accounts payable | $2.5M | -$911.0K | $939.0K | $687.0K | -$1.1M | -$886.0K | -$508.0K | $115.0K |
| Purchases of investments | $144.8M | $67.0K | $0 | $43.4M | $0 | $0 | $0 | $29.9M |
| Tax withholding on stock comp | $7.0K | $262.0K | $0 | $0 | $0 | $65.0K | $0 | $4.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $1.0M | $5.7M | $1.7M | $652.0K | $30.0M |
| Operating income | -$51.5M | -$80.6M | -$92.0M | -$103.3M | -$45.3M |
| Net income | -$48.8M | -$75.4M | -$87.3M | -$101.9M | -$45.0M |
| EPS (diluted) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 |
| EPS (basic) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 |
| Operating margin | -$5.2K | -$1.4K | -$5.5K | -$15.8K | -$151 |
| Net margin | -$4.9K | -$1.3K | -$5.3K | -$15.6K | -$150 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $91.0M | $91.0M | $159.6M | $205.3M | $298.6M |
| Total liabilities | $8.6M | $11.4M | $14.9M | $29.2M | $26.8M |
| Stockholders' equity | $82.4M | $79.6M | $144.7M | $176.2M | $271.8M |
| Total current assets | $82.5M | $79.2M | $143.2M | $184.6M | $288.3M |
| Total current liabilities | $7.1M | $8.9M | $11.5M | $25.0M | $24.6M |
| Cash & equivalents | $54.2M | $57.4M | $125.6M | $47.4M | $92.3M |
| Property, plant & equipment | $6.1M | $9.8M | $13.8M | $17.7M | $9.9M |
| Other non-current assets | $1.4M | $2.0M | $2.5M | $3.1M | $381.0K |
| Accounts payable | $2.1M | $2.4M | $1.6M | $7.2M | $10.0M |
| Deferred revenue (current) | — | — | — | — | $0 |
| Common stock & paid-in capital | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K |
| Retained earnings | -$430.5M | -$381.7M | -$306.3M | -$219.0M | -$117.1M |
| Accumulated other comprehensive income (loss) | $6.0K | $2.0K | $4.0K | -$877.0K | -$560.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$39.9M | -$60.5M | -$81.2M | -$94.5M | -$57.1M |
| Investing cash flow | -$7.9M | -$8.5M | $110.9M | $49.4M | -$10.4M |
| Financing cash flow | $44.6M | $787.0K | $48.6M | $171.0K | $1.9M |
| Free cash flow | -$40.0M | -$60.6M | -$81.6M | -$106.1M | -$65.0M |
| Capital expenditures | $71.0K | $59.0K | $407.0K | $11.6M | $7.9M |
| Depreciation & amortization | $3.7M | $3.8M | $4.0M | $3.1M | $1.4M |
| Share-based compensation | $7.0M | $9.5M | $6.9M | $6.5M | $5.5M |
| Change in accounts payable | -$318.0K | $832.0K | -$5.6M | -$2.8M | $7.9M |
| Purchases of investments | $43.4M | $93.6M | $79.7M | $132.4M | $204.1M |
| Tax withholding on stock comp | $65.0K | $451.0K | $53.0K | $0 | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding STTK as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-01-25 to 2026-07-06
Recent transactions
- Insiders have net sold 23,407 shares over the last 182 days, across 1 purchase and 6 sales.
- Most recent: Shukla Abhinav A. (Chief Technical Officer) — Option exercise of 12,153 shares on 2026-07-06.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)62,500 sh(1 txns)
Sales (open market)85,907 sh(6 txns)
Net Shares-23,407
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer | Option exercise | 2026-07-06 | 12,153 |
| Pandite Arundathy N. | Chief Medical Officer | Open market sale | 2026-06-30 | 30,000 |
| SIEGALL CLAY B | Reporting person | Open market purchase | 2026-06-09 | 62,500 |
| Stout Stephen | See Remarks | Grant / award | 2026-05-15 | 12,805 |
| Neill Andrew R | Chief Financial Officer | Grant / award | 2026-05-12 | 64,027 |
| Schreiber Taylor | Chief Executive Officer | Grant / award | 2026-05-12 | 25,610 |
| DeYoung Casi | Chief Business Officer | Tax withholding | 2026-01-25 | 2,286 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-06 | Shukla Abhinav A. | Chief Technical Officer | Option exercise | 12,153 | $3.57 |
| 2026-07-02 | Shukla Abhinav A. | Chief Technical Officer | Option exercise | 410 | $3.57 |
| 2026-07-02 | Shukla Abhinav A. | Chief Technical Officer | Open market sale | 410 | $7.01 |
| 2026-07-01 | Shukla Abhinav A. | Chief Technical Officer | Option exercise | 100 | $3.57 |
| 2026-07-01 | Shukla Abhinav A. | Chief Technical Officer | Open market sale | 100 | $7.07 |
| 2026-06-30 | Shukla Abhinav A. | Chief Technical Officer | Option exercise | 23,365 | $3.57 |
| 2026-06-30 | Shukla Abhinav A. | Chief Technical Officer | Open market sale | 23,365 | $7.08 |
| 2026-06-30 | Pandite Arundathy N. | Chief Medical Officer | Open market sale | 30,000 | $7.01 |
| 2026-06-09 | SIEGALL CLAY B | Reporting person | Open market purchase | 62,500 | $4.00 |
| 2026-05-22 | SIEGALL CLAY B | Reporting person | Grant / award | 128,054 | $1.08 |
| 2026-05-21 | Shukla Abhinav A. | Chief Technical Officer | Grant / award | 5,122 | $1.08 |
| 2026-05-15 | Stout Stephen | See Remarks | Grant / award | 12,805 | $1.08 |
| 2026-05-12 | Neill Andrew R | Chief Financial Officer | Grant / award | 64,027 | $1.08 |
| 2026-05-12 | Shukla Abhinav A. | Chief Technical Officer | Option exercise | 2,032 | $3.57 |
| 2026-05-12 | Shukla Abhinav A. | Chief Technical Officer | Open market sale | 2,032 | $7.01 |
| 2026-05-12 | Pandite Arundathy N. | Chief Medical Officer | Open market sale | 30,000 | $6.61 |
| 2026-05-12 | Schreiber Taylor | Chief Executive Officer | Grant / award | 25,610 | $1.08 |
| 2026-05-10 | Stout Stephen | See Remarks | Tax withholding | 968 | $6.85 |
| 2026-01-25 | Pandite Arundathy N. | Chief Medical Officer | Tax withholding | 3,195 | $4.15 |
| 2026-01-25 | Stout Stephen | See Remarks | Tax withholding | 593 | $4.15 |
| 2026-01-25 | DeYoung Casi | Chief Business Officer | Tax withholding | 2,286 | $4.15 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 22:52 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-11 | 8-K | 2026-08-11 | View on SEC.gov → |
| 2026-08-11 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-07 | 4 | 2026-07-02 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-09 | View on SEC.gov → |
| 2026-06-11 | 8-K | 2026-06-09 | View on SEC.gov → |
| 2026-06-09 | 4 | 2026-06-08 | View on SEC.gov → |
| 2026-06-09 | 4 | 2026-06-08 | View on SEC.gov → |
| 2026-06-09 | 8-K | 2026-06-08 | View on SEC.gov → |
Recent news
Headlines about STTK (Shattuck Labs, Inc.). Links open the publisher — we don’t host full articles.
-
Evercore Initiates Shattuck Labs(STTK.US) With Buy Rating, Announces Target Price $10
Moomoo · 2026-10-21 -
Shattuck Labs presents two UEG posters: what they mean for Shattuck Labs stock
AD HOC NEWS · 2026-10-21 -
Shattuck Labs, Inc. Dividends – FWB:82S
TradingView · 2026-10-20 -
(STTK) Movement Within Algorithmic Entry Frameworks
Stock Traders Daily · 2026-10-19 -
STTK Nov 2026 8.000 call (STTK261120C00008000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-17 -
STTK Nov 2026 7.000 call (STTK261120C00007000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-17 -
UBS upgrades Shattuck Labs stock to strong buy at USD 17 target - ad-hoc-news.de
ad-hoc-news.de · 2026-10-16 -
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
Yahoo · 2026-10-13
No headlines in this category right now — try “All”.